InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
T+90 hit rate
45%
T+90 mean return
+3.0%
Across 20 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Schenkein David P, Director. Officer active across 5 companies, notably AGIOS PHARMACEUTICALS, INC.. In total, 33 disclosures have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €2.1m. History available since 28 May 2021. The latest transaction was filed on 3 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations33 total
6,408 shares0Common StockSEC:0001578200-26-000004:0
166 shares0Common StockSEC:0001968202-25-000012:0
47,165 shares@ US$18.00100.0% of flowCommon StockSEC:0001714899-24-000219:0
3,388 shares0Common stockSEC:0001439222-24-000087:0
5,967 shares0Common StockSEC:0001714899-24-000136:0
11,858 shares@ US$31.646.2% of flowCommon stockSEC:0001439222-24-000042:0
47,731 shares@ US$31.6425.1% of flowCommon stockSEC:0001439222-24-000040:0
47,731 shares@ US$33.0526.2% of flowCommon stockSEC:0001439222-24-000040:1
20,411 shares@ US$31.6410.7% of flowCommon stockSEC:0001439222-24-000040:2
20,411 shares@ US$33.1911.2% of flowCommon stockSEC:0001439222-24-000040:3
42 shares0Common StockSEC:0001883850-24-000003:0
240 shares0Common StockSEC:0001104659-23-099992:0
4,975 shares0Common stockSEC:0001439222-23-000091:0
4,216 shares0Common StockSEC:0001714899-23-000096:0
16,363 shares@ US$9.052.4% of flowCommon stockSEC:0001439222-23-000058:0
20,000 shares@ US$9.053.0% of flowCommon stockSEC:0001439222-23-000056:0
20,000 shares@ US$9.053.0% of flowCommon stockSEC:0001439222-23-000055:0
20,000 shares@ US$9.053.1% of flowCommon stockSEC:0001439222-23-000041:0
20,000 shares@ US$9.053.0% of flowCommon stockSEC:0001439222-23-000020:0
20,000 shares@ US$9.053.0% of flowCommon stockSEC:0001439222-23-000010:0
20,000 shares@ US$9.053.0% of flowCommon stockSEC:0001439222-23-000008:0
5,986 shares0Common StockSEC:0001714899-22-000098:0
1,585 shares0Common stockSEC:0001439222-22-000051:0
2,775 shares0Common stockSEC:0001439222-22-000015:0
2,074 shares0Common StockSEC:0001209191-21-038390
25 of 33 declarations
About Schenkein David P
David P. Schenkein is a Director at AGIOS PHARMACEUTICALS, INC. and Denali Therapeutics Inc. He contributes to the governance of the companies and strategic decision-making. His expertise in the pharmaceutical sector allows him to make significant contributions to the companies' leadership.
